What is the virological support for reduced drug regimens? | Anne-Geneviève Marcelin, MD

European HIV Clinical Forum 2017

First Discussion Panel

European Workshop on Healthy Living with HIV 2016

Romy Mathys Q&A

European Workshop on Healthy Living with HIV 2016

Healthy Living from the community perspective | Romy Mathys

European Workshop on Healthy Living with HIV 2016

Yazdan Yazdanpanah Q&A

European Workshop on Healthy Living with HIV 2016

Examples of missed opportunities in avoiding long term toxicities and comorbidities | Yazdan Yazdanpanah, MD, PhD

European Workshop on Healthy Living with HIV 2016

Caring for the aging HIV infected patient: meeting the challenge | Giovanni Guaraldi, MD

European Workshop on Healthy Living with HIV 2016

Integrating Science Into The Clinic: Current and Future Use of Integrase Inhibitors | Marta Boffito, MD, PhD, FRCP

European Workshop on Healthy Living with HIV 2016

Long-term toxicities of commonly prescribed first line regimens, a 10 – 20 year horizon | José Arribas, MD

European Workshop on Healthy Living with HIV 2016

Missed the PrEP opportunity? | Laura Waters, MD, FRCP

European Workshop on Healthy Living with HIV 2016

Micro-elimination as a strategy to reach global elimination | Jeffrey Lazarus, PhD, MIH, MA

International Viral Hepatitis Elimination Meeting (IVHEM) 2017

Anton Pozniak Q&A

European Workshop on Healthy Living with HIV 2016

Prevention transmission strategies through strengthening the health system | Maia Butshashvili, MD, MS, PhD

International Viral Hepatitis Elimination Meeting (IVHEM) 2017

PrEP: who, when and how | Anton Pozniak, MD, FRCP

European Workshop on Healthy Living with HIV 2016

Prevention transmission strategies prior to infection - Incarceration | Lara Strick, MD, MS

International Viral Hepatitis Elimination Meeting (IVHEM) 2017

Prevention transmission strategies prior to infection - People who inject drugs | Diana Sylvestre, MD

International Viral Hepatitis Elimination Meeting (IVHEM) 2017

How to measure your success; globally and locally | Yvan Hutin, MD, PhD

International Viral Hepatitis Elimination Meeting (IVHEM) 2017

Real-life experiences - Egypt | Imam Waked, MD

International Viral Hepatitis Elimination Meeting (IVHEM) 2017

WHO status report: Global response to the strategic framework | Yvan Hutin, MD, PhD

International Viral Hepatitis Elimination Meeting (IVHEM) 2017

Setting the stage - Key challenges in elimination | Jordan Feld, MD, MPH

International Viral Hepatitis Elimination Meeting (IVHEM) 2017

The Challenge of Drug-Resistant TB in Children with HIV | Simon Schaaf, MMed, PhD

International Workshop on HIV & Pediatrics 2016

Option B+: Beyond ART – Experience with Retention and Outcomes | Landon Myer

International Workshop on HIV & Pediatrics 2016

It’s Not Just HIV: Complications and Research Priorities in Care of HIV-Infected Youth | Rashida Ferrand, MBBS, MRCP, MSc, DRM&H

International Workshop on HIV & Pediatrics 2016

Low-Resource Perspective on Adolescent Transition and Research Priorities | Mary-Ann Davies, MBChB, MMed, PhD, FC

International Workshop on HIV & Pediatrics 2016